On Friday, Neuronetics Inc (NASDAQ: STIM) opened lower -9.52% from the last session, before settling in for the closing price of $2.52. Price fluctuations for STIM have ranged from $0.52 to $5.92 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 2.71% annually for the last half of the decade. Company’s average yearly earnings per share was noted 56.57% at the time writing. With a float of $41.82 million, this company’s outstanding shares have now reached $68.44 million.
Neuronetics Inc (STIM) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Neuronetics Inc is 38.94%, while institutional ownership is 27.26%. The most recent insider transaction that took place on Aug 08 ’25, was worth 13,020,000. In this transaction 10% Owner of this company sold 3,500,000 shares at a rate of $3.72, taking the stock ownership to the 1,142,351 shares. Before that another transaction happened on Aug 08 ’25, when Company’s 10% Owner proposed sale 2,925,554 for $3.72, making the entire transaction worth $10,883,061.
Neuronetics Inc (STIM) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.04 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.24) by 0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.10% during the next five years compared to 2.71% growth over the previous five years of trading.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Check out the current performance indicators for Neuronetics Inc (STIM). In the past quarter, the stock posted a quick ratio of 2.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Let’s dig in a bit further. During the last 5-days, its volume was 3.15 million. That was better than the volume of 1.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.06%.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 2.10%, which indicates a significant decrease from 5.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.26 in the past 14 days, which was higher than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.92, while its 200-day Moving Average is $3.71. However, in the short run, Neuronetics Inc’s stock first resistance to watch stands at $2.46. Second resistance stands at $2.64. The third major resistance level sits at $2.75. If the price goes on to break the first support level at $2.16, it is likely to go to the next support level at $2.05. Assuming the price breaks the second support level, the third support level stands at $1.87.
Neuronetics Inc (NASDAQ: STIM) Key Stats
There are currently 68,486K shares outstanding in the company with a market cap of 156.15 million. Presently, the company’s annual sales total 74,890 K according to its annual income of -43,710 K. Last quarter, the company’s sales amounted to 38,110 K and its income totaled -10,120 K.
